Category: STAT Summit
-
At a gathering of biopharma executives, a moment of wonder — and also of worry
At a gathering of biopharma executives, a moment of wonder — and also of worry Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit on Oct. 15-16, that kind of moment came when one of the top biopharmaceutical executives in the world met a toddler in a tuxedo. Read the…
-
STAT+: Biotech leaders say uncertainty at FDA threatens drug development
STAT+: Biotech leaders say uncertainty at FDA threatens drug development BOSTON — Replimune Group and Capricor Therapeutics both seemed on track to receive long-awaited drug approvals from the Food and Drug Administration earlier this year. Then, amid tumult at the agency as the Trump administration took power, their applications were rejected. The companies’ CEOs talked…
-
Doctor groups need to ‘step up to the plate’ as CDC guidance becomes harder to trust, former leaders say
Doctor groups need to ‘step up to the plate’ as CDC guidance becomes harder to trust, former leaders say BOSTON — It’s getting harder to trust guidance coming out of the Centers for Disease Control and Prevention, creating an opening for physician groups to step up and fill the void, two former top agency officials…
-
‘Doctor Mike,’ the popular YouTube creator, faults AMA communication strategies to counter misinformation
‘Doctor Mike,’ the popular YouTube creator, faults AMA communication strategies to counter misinformation BOSTON — Mike Varshavski, a family physician and content creator who goes by Doctor Mike on YouTube, has made it his mission to combat medical misinformation. He’s attracted 14 million followers by communicating both clearly and entertainingly. He wishes leaders in medicine…
-
STAT+: CEO of GSK plays down its role in FDA effort to approve therapy for autism-related condition
STAT+: CEO of GSK plays down its role in FDA effort to approve therapy for autism-related condition BOSTON — The CEO of the drugmaker GSK on Wednesday said the company has had a minimal role in the Food and Drug Administration’s effort to update the prescribing information of a long-shelved drug so that it can…
-
STAT+: Eli Lilly and AstraZeneca top a consultancy’s ranking of drug company R&D
STAT+: Eli Lilly and AstraZeneca top a consultancy’s ranking of drug company R&D A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap — but when it comes to invention, AstraZeneca, with its wealth of experimental cancer and rare disease therapies, ranks above its…
-
Former FDA head Robert Califf says RFK Jr.’s vaccine rhetoric is ‘doing harm’ to Americans
Former FDA head Robert Califf says RFK Jr.’s vaccine rhetoric is ‘doing harm’ to Americans SAN FRANCISCO — Former Food and Drug Administration Commissioner Robert Califf said health secretary Robert F. Kennedy Jr.’s hesitance to endorse vaccines is harming the American public. “Fundamental vaccination saves millions of lives every year already, and he’s busy eroding public…